IRIS
MUSOLINO, Caterina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.679
EU - Europa 4.703
AS - Asia 845
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 4
AF - Africa 2
Totale 11.247
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.653
IE - Irlanda 1.503
SE - Svezia 1.234
CN - Cina 719
IT - Italia 604
UA - Ucraina 356
DE - Germania 273
FI - Finlandia 210
PL - Polonia 179
GB - Regno Unito 142
FR - Francia 58
IN - India 56
BE - Belgio 52
AT - Austria 32
VN - Vietnam 27
CA - Canada 21
NL - Olanda 17
IR - Iran 11
RU - Federazione Russa 11
SG - Singapore 10
AU - Australia 6
ES - Italia 6
KR - Corea 6
CH - Svizzera 5
MX - Messico 5
RO - Romania 5
TW - Taiwan 5
DK - Danimarca 4
EU - Europa 4
IL - Israele 4
NZ - Nuova Zelanda 4
CZ - Repubblica Ceca 3
NO - Norvegia 3
TR - Turchia 3
BR - Brasile 2
CO - Colombia 2
GR - Grecia 2
ID - Indonesia 2
BG - Bulgaria 1
EG - Egitto 1
GH - Ghana 1
IQ - Iraq 1
JP - Giappone 1
LT - Lituania 1
LV - Lettonia 1
PT - Portogallo 1
Totale 11.247
Salva come PNG Salva come JPEG
Città #
Dublin 1.503
Chandler 1.266
Jacksonville 800
Nyköping 723
Beijing 320
Messina 309
Ashburn 280
Princeton 279
Dearborn 268
Medford 258
Des Moines 212
Cambridge 209
Ann Arbor 185
Warsaw 174
Boardman 123
New York 79
Woodbridge 77
Wilmington 62
San Mateo 56
Brussels 52
Jinan 50
Shenyang 41
Nanjing 38
Hebei 36
Lancaster 36
Tianjin 34
Pune 33
Bremen 32
Vienna 32
Seattle 28
Dong Ket 27
Hangzhou 25
Houston 24
Strasbourg 23
Ningbo 20
Zhengzhou 20
Haikou 18
Rome 16
Helsinki 15
Norwalk 15
Auburn Hills 14
Falls Church 14
Washington 14
Milan 12
Lanzhou 11
Los Angeles 11
Augusta 10
Guangzhou 10
Hyderabad 10
Jiaxing 10
Ottawa 10
Palermo 10
Taizhou 10
Catania 9
Fuzhou 9
Nanchang 9
Changsha 8
Monmouth Junction 8
Taiyuan 8
Ardabil 7
Leawood 6
Amsterdam 5
Capoterra 5
Latina 5
Piazza Armerina 5
Redwood City 5
Cosenza 4
Ferrandina 4
Francofonte 4
Hefei 4
Modica 4
Petrosino 4
Turin 4
Acireale 3
Brindisi 3
Chapel Hill 3
Esher 3
Fremont 3
Gangdong-gu 3
Kelowna 3
Kunming 3
Lausanne 3
Madrid 3
Mumbai 3
Redmond 3
Saint Petersburg 3
Tappahannock 3
Arlington 2
Auckland 2
Avola 2
Barcelona 2
Berlin 2
Cajica 2
Civitanova Marche 2
Crosia 2
Edinburgh 2
Florence 2
Gropello Cairoli 2
Hanover 2
Impruneta 2
Totale 8.129
Salva come PNG Salva come JPEG
Nome #
Effect of therapeutic plasma exchange on plasma levels of oxidative biomarkers in a patient with thrombotic thrombocytopenic purpura 102
Diagnostic utility of Sudoscan for detecting Bortezomib-induced painful neuropathy 99
Raman spectroscopy differentiates between sensitive and resistant multiple myeloma cell lines 95
Low-energy laser irradiation promotes cellular damage in glucocorticoid-resistant multiple myeloma cells. 94
Phage-AgNPs complex as SERS probe for U937 cell identification 92
The cancer stem cell hypothesis: a guide to potential molecular targets. 90
Comportamento di alcuni indici della fibrinolisi in dislipidemici in corso di trattamento con sinfibrato" 86
Corneal Structural Changes in Nonneoplastic and Neoplastic Monoclonal Gammopathies 84
Role of the microbiota in hematologic malignancies. 83
L'ipersplenismo: attualità e prospettive future 82
Cutaneous adverse reactions to lenalidomide. 81
Altered Microrna Expression Profile in the peripheral Lymphomonocytes of Multiple Myeloma Patients with Bisphosphonate-Induced Osteonecrosis of the Jaw 77
Absence of the V617F JAK2 Mutation in the Lymphoid Compartment in a Patient with Essential Thrombocythemia and B-Chronic Lymphocytic Leukemia and in Two Relatives with Lymphoproliferative Disorders 76
Disappearance of Acquired Hemophilia A after Complete Remission in a Multiple Myeloma Patient. 76
Challenge test to bisphosphonates in patients with hypersensitivity reactions to drugs. 75
SIRT1 and SIRT2 Expression correlates with advanced disease and bone lesions in Multiple Myeloma 74
Extramedullary plasmacytoma of the maxilla simulating a maxillary radicular cyst: Quick diagnosis and management 73
Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies 73
E rosette formation in B cell chronic lymphocytic leukemia. 72
Novel therapeutic strategies in multiple myeloma: role of the heat shock protein inhibitors 71
Bisphosphonate-associated osteonecrosis of the jaw in patients with multiple myeloma and breast cancer. 71
Altered microRNA expression profile in the peripheral lymphoid compartment of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw 71
Bisphosphonates induce apoptosis of circulating endothelial cells in multiple myeloma patients and in subjects with bisphosphonate-induced osteonecrosis of the jaws 71
MDR-1 gene polymorphisms G2677T and C3435T in a case of Hodgkin's variant of Richter's syndrome 69
Patients with bisphosphonate-associated osteonecrosis of the jaw have unmodified levels of soluble vascular endothelial growth factor receptor 1. 68
Evaluation of the AGE/sRAGE Axis in Patients with Multiple Myeloma 68
Circulating levels of intercellular adhesion Molecule-1 (ICAM-1) and soluble Interleukin 2 receptors(IL-2R) in patients with B cell Chronic Lynphocityc Leukemia 65
ASSETTO EMATOLOGICO DI UN GRUPPO DI SOGGETTIAFFETTI DA MORBO DI COOLEY:STUDIO DEL COMPORTAMENTO DELL'ERITROPOIETINA PLASMATICA 65
Telomerase and telomere biology in hematological diseases: A new therapeutic target 65
How gene polymorphisms can influence clinical response and toxicity following R-CHOP therapy in patients with diffuse large B cell lymphoma 64
Evaluation of Interleukin-17 serum levels in patients with chronic myeloproliferative diseases. 63
ARA-C a basse dosi nelle sindrome mielodisplastiche in differenti stati evolutivi 63
Aggregazione piastrinica in dislipidemici in corso di trattamento con simfibrato 63
Immunoproteasome-selective and non-selective inhibitors: A promising approach for the treatment of multiple myeloma. 63
Curcumin ameliorates the in vitro efficacy of carfilzomib in human multiple myeloma U266 cells targeting p53 and NF-kB pathways 63
Angiogenesis in patients with biphosphonate-associated osteonecrosis of the jaw 62
A rare spinal localization of gray zone lymphoma without mediastinal involvement: A case report and review of literature 62
Absence of the V617F JAK2 mutation in the lymphoid compartment in a patient with essential thrombocythemia and B-chronic lymphocytic leukemia and n two relatives with lymphoproliferative disorders 61
Assenza della mutazione JAK2 V617F nel compartimento linfoide di un paziente affetto da trombocitemia essenziale e leucemia linfatica cronica a cellule B ed in due parenti affetti da disordini linfoproliferativi 61
Serum levels of soluble ICAM-1 in patients with malignant lymphoma in association with treatment response. 60
Serum levels of interleukin-16 in lymphoid malignancies. 60
Efficacia della chemioterapia convenzionale ad alte dosi in un caso di mieloma multiplo IgM primitivamente doppio-refrattario ai nuovi farmaci 60
Immunohistochemical evaluation of sarcoglycans and integrin in gingival epithelium of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw 59
Immunohistochemical evaluation of sarcoglycans and integrins in gingival epithelium of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw. 59
Increased levels of the soluble adhesion molecule E-selectin in patients with chronic myeloproliferative disorders and thromboembolic complications 58
A micro-Raman spectroscopic investigation of leukemic U-937 cells in aged cultures 58
Antiresorptive Agents and Anti-Angiogenesis Drugs in the Development of Osteonecrosis of the Jaw. 58
Amyloid myopathy presenting with rhabdomyolysis: Evidence of complement activation 57
Evaluation of circulating endothelial cells, VEGF and VEGFR2 serum levels in patients with chronic myeloproliferative diseases. 57
Beta 2 microglobulina ed emopatie maligne 57
Vaccination of multiple myeloma: Current strategies and future prospects 57
Elevated srum concentration of angiopoietin-2 in patients with multiple myeloma: correlation with markers of disease 56
ABERRANT EXPRESSION OF CANCER TESTIS ANTIGENS IN HEMATOLOGIC MALIGNANCIES 56
Circulating levels of intercellular adhesion molecule-1 (ICAM-1) and soluble interleukin 2 receptors (IL-2R) in patients with B cell chronic lymphocytic leukaemia. 56
Adoptive immunotherapy for hematological malignancies: Current status and new insights in chimeric antigen receptor T cells 56
Triplet vs doublet lenalidomide-containing regimens for the treatment of elderly patients with newly diagnosed multiple myeloma 56
EVALUATION OF DECORIN AND BIGLYCAN GENE EXPRESSION IN LYMPHOCYTES FROM PATIENTS WITH CHRONIC LYMPHATIC LEUKAEMIA. 55
Carbonyl groups serum levels are associated with CD38 expression in patients with B chronic lymphocytic leucemia. 55
Evaluation of hepatitis B and C virus infections in patients with non-Hodgkin's lymphoma and without liver disease 54
Lipid profile in hematologic neoplasms 53
Circulating microRNAs: New biomarkers in diagnosis, prognosis and treatment of cancer (Review). 53
Risk of occult hepatitis B virus infection reactivation in patients with solid tumours undergoing chemotherapy 53
A progression-risk score to predict treatment-free survival for early stage chronic lymphocytic leukemia patients 52
Vaccination strategies in lymphoproliferative disorders: Failures and successes 52
Severe dermatologic adverse reactions after exposure to lenalidomide in multiple myeloma patients with a positive HLA-DRB1*1501 and HLA-DQB1*0602. 52
SOLUBLE ANGIOGENIC FACTORS: IMPLICATIONS FOR CHRONIC MYELOPROLIFERATIVE DISORDERS 51
Evaluation des sous-populations lymphocytaires chez des travailleurs exposés a basse dose du benzene. Données préliminaires”. 51
Circulating endothelial progenitor cells and angiogenic serum factors in patients with chronic myeloproliferative diseases 51
MDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia: an impact on susceptibility and prognosis. 51
Recombinant human granulocyte colony-stimulating factor reverts vascular dysfunction 50
MARKERS OF ENDOTHELIAL AND PLATELET STATUS IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND PLYCYTHEMIA VERA 50
Purpuric gloves and socks syndrome caused by parvovirus B19 infection 50
Cardiac involvement in patients with hematologic malignancies. 50
Concentration of circulating endothelial progenitor cells (EPC) in normal pregnancy and in pregnant women with diabetes and hypertension 50
Efficacia di Nilotinib in un giovane paziente affetto da LMC ad alto rischio Sokal in fallimento dopo inatinib ad alte dosi 50
Hepatitis B Virus Causes Epigenetic Induction of Interleukin-8Production which in Turn Inhibits Interferon-alfa Antiviral Activity 50
Avascular Necrosis of Bone in Leukemia and Osteonecrosis of Jaw by Bisphosphonates 50
ABVD vs BEACOPP escalated in advanced-stage Hodgkin's lymphoma: Results from a multicenter European study 50
Risk stratification and early cardiotoxicity identification: organizational advantages and clinical impact of intrahospital cardiotoxicity network 50
JAK2 V617F-positive latent essential thrombocythemia and splanchnic vein thrombosis: the role of bone marrow biopsy for the diagnosis of myeloproliferative disease. 49
Patients with bisphosphonates-associated osteonecrosis of the jaw have reduced circulating endothelial cells 49
Decreased plasma levels of IL-33 could contribute to the altered function of Th2 Iymphocytes in patients with poIycythemia vera and essential thrombocythemia. 48
SIRT2 and SIRT3 expression correlates with redox imbalance and advanced clinical stage in patients with multiple myeloma 48
A multivariate analysis of Multiple Myeloma subtype plasma cells 48
Cellule endoteliali progenitrici circolanti e osteonecrosi mascellare da bifosfonati. 47
Increase in serum protein carbonyl groups is associated with more advanced stage of disease in multiple myeloma patients. 47
Possible role of Interleuki-31/33 Axis in Imatinib Mesylate-Associated Skin Toxicity 47
MicroRNA profiling in asthma: Potential biomarkers and therapeutic targets 47
The adipose organ and multiple myeloma: Impact of adipokines on tumor growth and potential sites for therapeutic intervention 47
Chromosome 1 abnormalities in elderly patients with newly diagnosed multiple myeloma treated with novel therapies. 46
Serum levels of Interleukin-16 in a multiple myeloma patient with cutaneous involvement 46
Serum levels of 2',5 oligoadenylate synthetase during interferon therapy in patients with B-cell chronic lymphocytic leukemia 46
Increase of IL-17, IL-22 and IL-23 serum levels induced by immunoglobulin infusion for Parvovirus-B associated Pure Red Cell Aplasia in a renal transplant recipient. 46
Prognostic value of serum thymidine kinase and beta 2 microglobulin in subjects affected by multiple myeloma 46
Curcumin Ameliorates the In Vitro Efficacy of Carfilzomib in Human Multiple Myeloma U266 Cells Targeting p53 and NF-κB Pathways. 46
FITC-labelled clone from phage display for direct detection of leukemia cells in blood 46
Changes in serum interleukin-8 and sRAGE levels in multiple myeloma patients 46
A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma 46
Differences in transplant-related complications between hematologic malignancies and solid tumors receiving high-dose chemotherapy and autologous peripheral blood stem cell transplantation 45
MULTIDRUG RESISTANCE-1 GENE POLYMORPHISM ASSOCIATED WITH THE NEW MARKER OF DISEASE PROGRESSION AND POOR PROGNOSIS IN b-CELL CHRONIC LIMPHATIC LEUKEMIA 45
Totale 6.037
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.524
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.524
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201931 0 0 0 0 0 0 0 0 0 0 17 14
2019/20201.523 177 76 13 72 35 248 209 145 27 243 258 20
2020/20211.766 211 38 300 91 150 174 36 170 133 243 120 100
2021/20221.629 16 118 24 73 54 22 99 64 55 223 220 661
2022/20234.570 409 389 214 408 311 464 53 229 1.855 27 146 65
2023/2024923 99 195 70 83 97 246 26 70 11 26 0 0
Totale 11.635